Doctor reacts to AI breast cancer tool
The providers of Clairity Breast, a new FDA-approved AI tool, claim their tech provides an accurate five-year risk assessment for breast cancer, for just $249.
Dr.
Céline Gounder shares her thoughts.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cbsnews.com — the content belongs to CBS News Technology.